Unilab Health At-Home Testing
Ovarian Reserve Test (AMH)
Ovarian Reserve Test (AMH)
Test Details
Included in test: Anti-Müllerian Hormone
Sample type: Blood
Sample collection: At-home Capillary Blood Collection Device
Age: 18 or older
Payment: Credit Card
Results: 1-2 days once sample is received at the lab
More About The Unilab Ovarian Reserve Test (AMH)
The Unilab Ovarian Reserve Test is a simple and accurate way to measure your ovarian reserve (the number of eggs that are available for possible fertilization).
This test measures AMH (antimüllerian hormone), which is a hormone produced by your ovaries. As your AMH decreases with age, so does your ovarian reserve. Simply said, as you get older, your AMH is expected to decrease.
While this test does not predict if you will get pregnant, it can provide a snapshot into your reproductive health. If your egg supply is decreasing too quickly, it could reveal a shorter window for you to get pregnant
We advise you share your results with your healthcare provider. Together, you can discuss your options so you can make informed decisions about your reproductive journey.
Share
Customer Reviews
Why Consider This Test?
-
Suspected or Diagnosed Infertility
Fertility is complex. Studies indicate that up to 15% of couples trying to conceive a child will experience infertility. Many factors, including AMH, are considered when assessing your fertility. AMH testing assessment included in most fertility assessments and can be a helpful information to discuss with your healthcare provider.
-
Considering IVF or Egg Preservation
Research shows that AMH levels correlate with the number of oocytes (eggs) retrieved after stimulation and can help predict ovarian response for women undergoing IVF. This information is also helpful in making decisions about egg retrieval treatments (egg freezing). Freezing eggs can help preserve reproductive options for the future.
-
Reproductive Curiosity & Planning
In woman over 18 who have not experienced infertility, a single AMH test should not be used to determine
fertility or predict pregnancy. However, tracking your levels over time can be informative. Rapidly declining AMH levels may indicate a shorter reproductive window. It is always best to discuss your reproductive options and planning with your healthcare provider.
Testing Performance
-
FDA Approved Test
Unilab has been performing this test using an FDA kit since 2005.
-
Validated In-House
All tests are run in-house on our new validated collection device.
-
Age-Specific Results
Results are customized based on a 2-year age window.
Here's How it Works
-
Purchase Test
Place your order online. A medical professional will review your order. Expect to receive a test kit within 2-3 days.
-
Collect Sample
Follow the instructions in your kit to collect your sample. Send your sample back to Unilab using the prepaid envelope.
-
Review Results
Results are ready within 1-2 days of receiving your sample. You will receive a text notification when your test results are ready.
Frequently Asked Questions
Who should take this test?
An AMH Test may be offered to any woman who has infertility or at high risk for infertility. Infertility is the failure to achieve pregnancy within 12 months of unprotected sex or donor insemination in woman who are younger than 35, or 6 months for women older than 35.
When should my sample of blood be collected?
Because AMH remains stable during your menstrual cycle, it can be collected any time or day of the menstrual cycle. Fasting before blood collection is not required.
What will the results tell me?
AMH testing is a simple way to measure your ovarian reserve. Ovarian reserve can predict your future response to ovarian stimulation. AMH results should be assessed in the context of a woman’s age.
Are there limitations to this test?
Yes. Currently, AMH is one of the most accurate and reliable markers of ovarian reserve. However, data does not support testing for many diagnoses. The following is a list of such conditions.
· AMH testing should not be used as a fertility test for women who are not infertile or who have untested fertility.
· Routine AMH testing for prediction of pregnancy loss is not recommended.
· AMH testing is not useful in predicting the likelihood of unassisted pregnancy in women with infertility.
· AMH testing does not appear to predict pregnancy after OS/IUI for unexplained infertility.
· Extremely low levels of AMH should not be used to refuse treatment in IVF.
· AMH may only have a weak association with egg quality, pregnancy rates, and live birth rates.
· AMH levels may be decreased in women using hormonal birth control. Results should be interpreted with caution.